Stem cell expansion during carcinogenesis in stem cell-depleted conditional telomeric repeat factor 2 null mutant mice

Oncogene

Volumn 32, Issue 43, 2013, Pages 5156-5166

  Bojovic, B ^a   Ho, H Y ^a   Wu, J ^a   Crowe, D L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

apoptosis; DNA damage; genomic instability; telomere

Indexed keywords

TELOMERIC REPEAT BINDING FACTOR 2;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DYSKERATOSIS CONGENITA; EPIDERMIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; METASTASIS; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STEM CELL EXPANSION; TELOMERE SHORTENING;

ANIMALS; CARCINOGENESIS; DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICE, KNOCKOUT; NEOPLASTIC STEM CELLS; TELOMERE; TELOMERE SHORTENING; TELOMERIC REPEAT BINDING PROTEIN 2;

MUS;

EID: 84886769277     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.555     Document Type: Article

References (50)

1. de Lange T. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-2110
2. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end to end fusions. Cell 1998; 92: 401-413
3. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53 and ATM dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283: 1321-1324
4. Smogorzewska A, de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J 2002; 21: 4338-4348
5. Denchi EL, de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007; 448: 1068-1071
6. Celli GB, de Lange T. DNA processing is not required for ATM mediated telomere damage response after TRF2 deletion. Nature Cell Biol 2005; 7: 712-718
7. Dimitrova N, Chen YCM, Spector DL, de Lange T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 2008; 456: 524-528
8. Deng Y, Guo X, Ferguson DO, Chang S. Multiple roles for MRE11 at uncapped telomeres. Nature 2009; 460: 914-918
9. Attwooll CL, Akpinar M, Petrini JHJ. The Mre11 complex and the response to dysfunctional telomeres. Mol Cell Biol 2009; 29: 5540-5551
10. Dimitrova N, de Lange T. Cell cycle dependent role of MRN at dysfunctional telomeres: ATM signaling dependent induction of nonhomologous end joining (NHEJ) in G1 and resection mediated inhibition of NHEJ in G2. Mol Cell Biol 2009; 29: 5552-5563
11. Wang RC, Smogorzewska A, de Lange T. Homologous recombination generates t loop sized deletions at human telomeres. Cell 2004; 119: 355-368
12. Bailey SM, Cornforth MN, Kurimasa A, Chen DJ, Goodwin EH. Strand specific postreplicative processing of mammalian telomeres. Science 2001; 293: 2462-2465
13. Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M et al. Targeting assay to study the cis functions of human telomeric proteins: Evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 2002; 22: 3474-3487
14. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446-2449
15. Rossi DJ, Jamieson CHM, Weissman IL. Stem cells and the pathways to aging and cancer. Cell 2008; 132: 681-696
16. Fuchs E. The tortoise and the hair: Slow cycling cells in the stem cell race. Cell 2009; 137: 811-819
17. Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, Blasco MA. The longest telomeres: A general signature of adult stem cell compartments. Genes Dev 2008; 22: 654-667
18. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S et al. Capturing and profiling adult hair follicle stem cells. Nature Biotechnol 2004; 22: 411-417
19. Fuchs E. Scratching the surface of skin development. Nature 2007; 445: 834-842
20. Cotsarelis G. Epithelial stem cells: A folliculocentric view. J Invest Derm 2006; 126: 1459-1468
21. Fuchs E. Skin stem cells: Rising to the surface. J Cell Biol 2008; 180: 273-284
22. Flores I, Cayuela ML, Blasco MA. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005; 309: 1253-1256
23. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005; 436: 1048-1052
24. Siegl-Cachedenier I, Flores I, Klatt P, Blasco MA. Telomerase reverses epidermal hair follicle stem cell defects and loss of long term survival associated with critically short telomeres. J Cell Biol 2007; 179: 277-290
25. Munoz P, Blanco R, Blasco MA. Role of TRF2 telomeric protein in cancer and ageing. Cell Cycle 2006; 5: 718-721
26. Blanco R, Munoz P, Flores JM, Klatt P, Blasco MA. Telomerase abrogation dramatically accelerates TRF2 induced epithelial carcinogenesis. Genes Dev 2007; 21: 206-220
27. Stout GJ, Blasco MA. Genetic dissection of the mechanisms underlying telomere associated diseases: Impact of the TRF2 telomeric protein on mouse epidermal stem cells. Disease Models Mech 2009; 2: 139-156
28. Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, Haruma K et al. Expression of telomeric repeat binding factor 1 and 2 and TRF1 interacting nuclear protein 2 in human gastric carcinoma. Int J Oncol 2001; 19: 507-512
29. Oh BK, Kim YJ, Park C, Park YN. Upregulation of telomere binding proteins TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 2005; 166: 73-80
30. Lantuejoul S, Raynaud C, Salameire D, Gazzeri S, Moro-Sibilot D, Soria JC et al. Telomere maintenance and DNA damage responses during lung carcinogenesis. Clin Cancer Res 2010; 16: 2979-2988
31. Heath J, Langton AK, Hammond NL, Overbeek PA, Dixon MJ, Headon DJ. Hair follicles are required for optimal growth during lateral skin expansion. J Invest Derm 2009; 129: 2358-2364
32. Hockemeyer D, Palm W, Wang RC, Couto SS, de Lange T. Engineered telomere degradation models dyskeratosis congenita. Genes Dev 2008; 22: 1773-1785
33. He H, Wang Y, Guo X, Ramchandani S, Ma J, Shen MF et al. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol Cell Biol 2009; 29: 229-240
34. Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P et al. Cutaneous cancer stem cell maintenance is dependent on b-catenin signaling. Nature 2008; 452: 650-653
35. Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 2007; 5: 351-362
36. Liu Y, Lyle S, Yang Z, Cotsarelis G. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Derm 2003; 121: 963-968
37. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M et al. Defining the epithelial stem cell niche in the skin. Science 2004; 303: 359-363
38. Callicot RJ, Womack JE. Real time PCR assay for measurement of mouse telomeres. Comparative Med 2006; 56: 17-22
39. Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nature Med 2005; 11: 1351-1354
40. Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clinics N Am 2009; 23: 215-231
41. Trempus CS, Morris RJ, Ehinger M, Elmore A, Bortner CD, Ito M et al. CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res 2007; 67: 4173-4181
42. Denchi EL, Celli G, de Lange T. Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Genes Dev 2006; 20: 2648-2653
43. Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, Man S et al. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev 2007; 21: 2495-2508
44. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L et al. Telomere dysfunction promotes nonreciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645
45. Kusumbe AP, Bapat SA. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 2009; 69: 9245-9253
46. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G et al. Stem like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 2010; 285: 4931-4940
47. Martinez P, Thanasoula M, Munoz P, Liao C, Tejera A, McNees C et al. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 2009; 23: 2060-2075
48. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004; 118: 635-648
49. Clayton E, Doupe DP, Klein AM, Winton DJ, Simons BD, Jones PH. A single type of progenitor cell maintains normal epidermis. Nature 2007; 446: 185-189
50. Snippert HJ, Haegebarth A, Kasper M, Jaks V, van Es JH, Barker N et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 2010; 327: 1385-1389